tiprankstipranks
Design Therapeutics (DSGN)
NASDAQ:DSGN
US Market

Design Therapeutics (DSGN) Balance Sheet

68 Followers

Design Therapeutics Balance Sheet

Design Therapeutics's total assets for Q3 2023 were $299.87M, a decrease of -3.77% from the previous quarter. DSGN total liabilities were $14.91M for the fiscal quarter, a 0.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 341.14M$ 390.56M$ 36.52M$ 90.00K
Total Liabilities
$ 13.83M$ 8.43M$ 47.83M$ 3.73M
Total Equity Gross Minority
$ 327.27M$ 382.13M$ -11.31M$ -3.64M
Total Capitalization
$ 330.36M$ 382.13M$ -11.31M$ -3.64M
Preferred Stock Equity
----
Capital Lease Obligations
--$ 0.00-
Currency in USD

Design Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis